# SpineMark Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spinemark

- Industry: Healthcare Specialists
- Headquarters: San Diego, US
- Website: www.spinemark.com
- Total disclosed funding: $10M
- Latest round: Series A (Dec 13, 2005)
- Investors on record: 1

## About

SpineMark Corporation specializes in integrated healthcare delivery systems dedicated to operative and non-operative spinal treatments, enhancing patient care through specialized facilities and clinical research services.SpineMark Corporation, founded in 2004 and headquartered in San Diego, US, focuses on innovative spinal treatment solutions. The company secured its first and only deal on December 13, 2005, raising USD 10 mn in a Series A funding round led by Upstream Ventures. The co-CEOs are Marcy Rogers and Michelle Caissie.SpineMark Corporation is a leader in the development of integrated healthcare delivery systems specifically tailored for operative and non-operative spinal treatments. The company's core offerings include the establishment of Spine Destination Centers, which serve as specialized facilities for spinal care, and Clinical Research Organization services that support groundbreaking clinical trials. These services are designed to enhance treatment options for patients suffering from spinal conditions, thereby addressing the critical need for effective management of such ailments. SpineMark collaborates closely with medical professionals, FDA sponsors, and healthcare providers to ensure that its offerings meet the highest standards of care and innovation. The company primarily targets markets across the United States, where it aims to advance spinal health through its comprehensive approach.SpineMark Corporation generates revenue through multiple streams, including service contracts with healthcare providers and partnerships with clinical trial sponsors. The transaction structure typically involves B2B engagements, whereby healthcare institutions pay for access to SpineMark's destination centers and clinical research capabilities. Pricing plans may be established based on the scope of services provided, with specific agreements tailored to the individual needs of partner organizations. Flagship offerings, such as the Spine Centers of Excellence, are integral to the company's revenue model, positioning SpineMark as a pivotal player in the spinal health market. By aligning its services with the demands of healthcare providers and regulatory requirements, SpineMark effectively enhances its market presence and financial sustainability.SpineMark Corporation plans to leverage the USD 10 mn raised in its latest funding round to develop new products and enhance existing services. The company is focused on launching innovative spinal treatment technologies by late 2023 and expanding its operations into emerging markets across North America and Europe before the end of 2024. This expansion is aimed at increasing accessibility to its specialized services and further improving patient outcomes in spinal health.

## Funding rounds

- Series A, Dec 13, 2005, $10M — Upstream Ventures

## Investors

- Upstream Ventures (https://capitalatlas.ai/funds/upstream-ventures) — Series A